SCHEMBL2401347

SCHEMBL2401347

CC(C)N1CCN(C(=O)[C@H]2CC[C@H](NS(=O)(=O)c3ccc(Cl)nc3)CC2)CC1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.55
HRH3 Q9Y5N1 1/20 0.44
CHRM1 P11229 1/20 0.44
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
CNR1 P21554 3/20 0.43
MMP2 P08253 1/20 0.42
MMP13 P45452 1/20 0.42
TSHR P16473 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
F13A1 P00488 1/20 0.40
TGM2 P21980 1/20 0.40
TGM1 P22735 1/20 0.40
SFRP1 Q8N474 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
PKM P14618 1/20 0.39
F10 P00742 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2402029 0.87 CNR1 (0.55) ALDH1A1HRH3MEN1KMT2ACNR1
SCHEMBL2402023 0.87 CNR1 (0.55) ALDH1A1HRH3MEN1KMT2ACNR1
SCHEMBL2405216 0.84 MEN1 (0.47) ALDH1A1HRH3MEN1KMT2ACNR1
SCHEMBL2405219 0.84 MEN1 (0.47) ALDH1A1HRH3MEN1KMT2ACNR1
SCHEMBL2405890 0.84 MEN1 (0.47) ALDH1A1HRH3MEN1KMT2ACNR1
SCHEMBL2400297 0.84 MEN1 (0.50) ALDH1A1HRH3MEN1KMT2ACNR1
SCHEMBL2400299 0.84 MEN1 (0.50) ALDH1A1HRH3MEN1KMT2ACNR1
SCHEMBL2403512 0.84 ALDH1A1 (0.61) ALDH1A1HRH3CHRM1MEN1KMT2A
SCHEMBL2402137 0.84 ALDH1A1 (0.58) ALDH1A1HRH3CHRM1MEN1KMT2A
SCHEMBL2401399 0.83 DRD2 (0.51) ALDH1A1HRH3MEN1KMT2ACNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8017773-B2 Cyclohexyl sulfonamide derivatives HOFFMANN-LA ROCHE INC. (US) 2011-09-13 US disclosed
US-20100120791-A1 CYCLOHEXYL SULFONAMIDE DERIVATIVES NETTEKOVEN MATTHIAS 2010-05-13 US disclosed
US-20070173511-A1 Cyclohexyl sulfonamide derivatives F. HOFFMANN-LA ROCHE AG (CH) 2007-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100120791-A1 CYCLOHEXYL SULFONAMIDE DERIVATIVES HRH3, HRH4, HRH1 ALDH1A1 430/4885HRH3 1/4885CHRM1 67/4885
US-20070173511-A1 Cyclohexyl sulfonamide derivatives HRH3, HRH4, HRH1 ALDH1A1 430/4885HRH3 1/4885CHRM1 67/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.